NCT01464008
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
- Locations
-
- Beijing Ditan hospital,Capital Medical University Beijing, Beijing Municipality, China
Clinical trial condition
Hepatitis C, Chronic
Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.
699 public trials
3 recruiting studies
Hepatitis C, Chronic trial results
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
- Locations
-
- Herne, Germany
NCT01846832
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
- Locations
-
- Linz, Austria
- Vienna, Austria
- Brussels, Belgium
- Edegem, Belgium
NCT01544582
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
- Locations
-
Not specified
NCT01399619
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- 1220.19.0045 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
- 1220.19.0007 Boehringer Ingelheim Investigational Site Palm Springs, California, United States
- 1220.19.0031 Boehringer Ingelheim Investigational Site San Francisco, California, United States
- 1220.19.0005 Boehringer Ingelheim Investigational Site Washington D.C., District of Columbia, United States
NCT01358864
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- 1220.7.0091 Boehringer Ingelheim Investigational Site North Little Rock, Arkansas, United States
- 1220.7.0082 Boehringer Ingelheim Investigational Site Englewood, Colorado, United States
- 1220.7.0095 Boehringer Ingelheim Investigational Site Palm Harbor, Florida, United States
- 1220.7.0039 Boehringer Ingelheim Investigational Site Columbus, Georgia, United States
NCT02753699
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Novartis Investigative Site La Jolla, California, United States
- Novartis Investigative Site San Diego, California, United States
- Novartis Investigative Site Ventura, California, United States
- Novartis Investigative Site Bradenton, Florida, United States
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Novartis Investigative Site San Diego, California, United States
- Novartis Investigative Site San Diego, California, United States
- Novartis Investigative Site Ventura, California, United States
- Novartis Investigative Site Bradenton, Florida, United States
NCT02716779
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Berlin, Germany
- Frankfurt am Main, Germany
- Frankfurt am Main, Germany
- Hanover, Germany
Completed
Double-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve Subjects
NCT00807001
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C (HCV), +15 more
- Locations
-
Not specified